Device Trial Radar · NCT03673449
Evaluate the Reconstruction of Digital Nerve Defects in Humans Using an Implanted Silk Nerve Guide
Last checked: Nov 20, 2026Latest source record: Mar 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4
Actual
Start
Mar 22, 2019
Primary completion
Mar 2021
Study completion Mar 2021
Sponsor
- Lead sponsor
- Silk Biomaterials srlNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 17, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to ascertain the feasibility and safety of the procedure using SilkBridge - a biocompatible silk fibroin-based scaffold - for the regeneration of sensory nerve fibres and follow it up together with the reinnervation of the target organs (sensory receptors in the skin).
Conditions
- Peripheral Nerve Injury Digital Nerve Hand
Interventions
SilkBridgeDevice
SilkBridge is a biocompatible silk fibroin-based scaffold, which recruits the patients' own cells to remodel or regenerate the nerve, without pre-seeding of the scaffold nor biological/chemical treatments.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of SilkBridgeTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Klinik für Plastische Chirurgie und Handchirurgie - UniversitätsSpital Zürich
Zurich, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.